The 2nd Edition of the International Cancer and Precision Oncology Conference presents an advanced scientific session on Cancer Genetics and Genomics, highlighting how genetic and molecular insights are revolutionizing cancer diagnosis, treatment, and prevention.
📅 November 23–25, 2026
📍 Singapore & Virtual
🔍 Scientific Overview
Cancer
Genetics and Genomics play a critical role in understanding how genetic
alterations influence tumor development, progression, and therapeutic response.
This session explores both inherited and acquired mutations and their impact on
personalized cancer care.
🧬 Key Focus Areas:
- Cancer Genome Projects and
large-scale sequencing advancements
- Hereditary cancer syndromes
and genetic counseling strategies
- Genomic biomarkers in
targeted therapy and precision medicine
- Epigenetic modifications and
their role in cancer progression
🧠 Understanding Cancer Through Genetics
Cancer
arises from a complex interplay of germline and somatic mutations:
- Germline mutations are inherited and increase
lifetime cancer risk
- Somatic mutations develop during life and
drive tumor growth
Advances
in sequencing technologies now allow researchers to uncover complex genomic
landscapes, enabling more accurate diagnosis and treatment planning.
⚙️ Expanding the Scope of Genomics
Modern
cancer genomics goes beyond single mutations to include:
- Chromosomal rearrangements
- Copy number variations
- Epigenetic changes
- Transcriptomic profiling
These
insights help define molecular subtypes of cancer, improving prognostic
accuracy and guiding targeted therapies.
🧬 Hereditary Cancer & Clinical Impact
Identifying
hereditary cancer syndromes allows:
✔️ Early risk detection
✔️ Preventive strategies
✔️ Personalized patient care
✔️ Family counseling and genetic testing
This
session highlights ethical and clinical considerations in implementing genetic
testing in oncology.
🔄 Tumor Evolution & Treatment
Resistance
Cancer is
dynamic. Tumors evolve over time, developing resistance to therapies.
- Clonal evolution drives
disease progression
- Liquid biopsies enable
real-time genomic monitoring
- Adaptive treatment
strategies improve long-term outcomes
🚀 Future of Precision Oncology
Genomics
is accelerating innovation through:
- Biomarker-driven therapies
- Genomic clinical trials
- AI and bioinformatics
integration
- Global data-sharing
initiatives
This
session emphasizes interdisciplinary collaboration in shaping the future of
oncology.
🌍 About the Conference
The 2nd
International Cancer and Precision Oncology Conference is a global platform
connecting oncologists, researchers, and healthcare professionals to explore
innovations in cancer science.
🔗 Important Links
👉 Website: https://cancer.miconferences.com/
👉 Register: https://cancer.miconferences.com/register
👉 Submit Abstract: https://cancer.miconferences.com/abstract-submission
👉 Contact: https://cancer.miconferences.com/contact
📞 Contact Information
📧 cancer@mathewsconference.com
📞 +1 (312) 462-4448
📱 WhatsApp: +1 (424) 377 0967
🏢 Organizer
Mathews
International LLC, Chicago, USA
🔖 Tags:
#CancerGenomics
#PrecisionOncology #CancerResearch #Genetics #OncologyConference #Epigenetics
#Biomarkers #CancerCare #MedicalConference #ClinicalResearch
